Alphanosos is a privately held company incorporated in November 2014 in France. We are primareleveraging our disruptive, AI-based, proprietary discovery process to discover and patent active ingredients and products based on plants with a history of safe human consumption to replace, with superior efficacy and reduced risks of side effects, many of the chemical products used as therapeutic drugs and technical ingredients in the human and animal health, wellbeing, and bioproduction industries. Early revenue is already generated by licenses for cosmetic usage of certain of these products, to be soon followed with licenses for veterinary applications and later for human drugs.

Our initial focus is on new antibiotics and anti-cancer products, with first products already in the post-discovery phase and a first patent application on anti-staphylococci products, for which we already obtained topical and systemic animal model results.